Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573
Gothenburg, Sweden. 12 November 2025. Mölnlycke Health Care, a global leader in MedTech, is the first company to donate a patent to SKF’s groundbreaking digital platform, The Patent Bay – taking bold action to harness collaboration and accelerate innovation in sustainable healthcare.

“We are proud to be part of this pioneering initiative,” says Zlatko Rihter, CEO of Mölnlycke Health Care. “Our purpose is to revolutionise care for people and planet. Supporting The Patent Bay is a powerful way to help turn that purpose into action.”
Today’s healthcare systems are under immense pressure to deliver the right care to the right patients, often with fewer resources. Mölnlycke believes that embracing partnerships, collaboration and openness are key to overcoming these challenges. By contributing to The Patent Bay, Mölnlycke is helping unlock new opportunities to help shape more sustainable healthcare systems for the future.
Mölnlycke is sharing a patent family relating to a method to determine a patient’s risk score. The innovation uses patient data to help caregivers predict risks and tailor treatments more effectively. By comparing a patient’s health profile to large-scale models, the patented method may improve treatment accuracy, reduce unnecessary interventions and lower healthcare costs.
Mölnlycke is making its patent freely accessible to innovators, entrepreneurs, researchers and healthcare providers worldwide, with the ultimate aim to improve patient outcomes.
“The Patent Bay was founded to accelerate progress through open knowledge and shared innovation. Mölnlycke Health Care’s decision to share smarter patient risk scoring highlights the power of collaboration—enabling better care and advancing healthcare for all. It’s a clear reminder that sharing drives meaningful progress for people, society and the planet,” says Annika Ölme, CTO and Senior Vice President, Technology Development at SKF.
Zlatko Rihter adds, “We encourage other organisations to join us in contributing to The Patent Bay to help drive open innovation for a more sustainable future.”
For more information please contact:

Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573
Note to editors
About The Patent Bay
The Patent Bay is a unique platform for sharing patents related to sustainable development, free of charge. It aims to accelerate technologies with the potential to advance sustainability through openness and collaboration. By taking a new approach to industrial innovation and rethinking how it is shared, it removes traditional barriers around patents – making sustainable technologies freely accessible, without the complex licensing or governance structures that often slow collaboration. The initiative reflects a shift from ownership to openness, and represents a practical, collaborative approach to industrial responsibility in the climate era. thepatentbay.com
Mölnlycke has further strengthened its sustainability performance in the latest EcoVadis assessment, achieving a ranking in the 98th percentile.
Dartford and Gravesham NHS Trust in the UK has adopted Steriwave® nasal photodisinfection for elective orthopaedic surgery, working with Mölnlycke and Ondine Biomedical to strengthen its approach to surgical site infection prevention.
Gothenburg, Sweden. 3 November 2026. Mölnlycke® announces the appointment of Anders Andersson as Chief Executive Officer (CEO) of Mölnlycke Health Care and Fredrik Wallefors as President of Surgical, effective 1 January 2027.
Mölnlycke is partnering with DEBRA International, the world’s leading epidermolysis bullosa (EB) patient advocacy network, to deepen understanding of the needs of people living with EB and help advance wound care for the global EB community.
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
In this role, Martin will lead the joint venture's operations and growth strategy in China, with responsibility for commercial execution, organisational leadership, governance and delivery of growth ambitions in one of the world's largest wound care markets.
Mölnlycke has joined the American Limb Preservation Society (ALPS) as an official Gold Strategic Partner, reinforcing a shared commitment to improving outcomes for patients at risk of amputation due to diabetic foot complications.
At Mölnlycke Health Care, we work alongside clinicians, researchers and healthcare experts to advance evidence-based care and help raise standards for post-operative care.